Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 138.50
0.00 (0.00%)
May 8, 2026, 1:30 PM CST
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 12.13 billion as of May 8, 2026. Its market cap has decreased by -3.92% in one year.
Market Cap
12.13B
Enterprise Value
11.74B
Revenue
1.02B
Ranking
n/a
PE Ratio
28.38
Stock Price
138.50
Market Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 12.13B, an increase of 138.07%. That is a compound annual growth rate of 12.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 12.13B | -15.55% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 15.90B |
| Polaris Group | 15.52B |
| AP Biosciences | 14.80B |
| EirGenix | 13.95B |
| TaiMed Biologics | 13.51B |
| CHO Pharma | 12.24B |
| Locus Cell | 12.00B |
| Tanvex BioPharma | 10.58B |